China Universal Asset Management Company’s Nautilus Biotechnolgy NAUT Stock Holding History

China Universal Asset Management Company’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-24,121	Closed	-$68.7K	–	515
2024 Q3	$68.7K	Buy	24,121 +9,404	+64%	+$24.3K	0.01%	377
2024 Q2	$34.4K	Sell	14,717 -9,359	-39%	-$24.4K	﹤0.01%	376
2024 Q1	$70.8K	Buy	24,076 +9,624	+67%	+$27.3K	0.01%	394
2023 Q4	$43.2K	Buy	14,452 +11,248	+351%	+$32.2K	0.01%	382
2023 Q3	$10.1K	Buy	3,204 +1,567	+96%	+$5.1K	﹤0.01%	344
2023 Q2	$6.33K	Sell	1,637 -55	-3%	-$158	﹤0.01%	348
2023 Q1	$4.69K	Buy	1,692 +425	+34%	+$891	﹤0.01%	370
2022 Q4	$2.28K	Buy	1,267 +99	+8%	+$191	﹤0.01%	362
2022 Q3	$2K	Buy	+1,168	New	+$2.94K	﹤0.01%	353

Other funds holding NAUT

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

China Universal Asset Management Company's NAUT Position: Q4 2024 in Review

China Universal Asset Management Company sold out of Nautilus Biotechnolgy (NAUT) in Q4 2024, closing a stake of 24,121 shares — an estimated $68.7K sold.

China Universal Asset Management Company first reported a position in NAUT in Q3 2022 and held it in 9 quarters. The position peaked at $70.8K in Q1 2024. 88 funds tracked by Wall St. Rank hold NAUT as of Q4 2024.

China Universal Asset Management Company reported no remaining Nautilus Biotechnolgy position as of Q4 2024 after selling out during the quarter.
China Universal Asset Management Company sold 24,121 Nautilus Biotechnolgy shares in Q4 2024, an estimated $68.7K.
China Universal Asset Management Company first reported a position in Nautilus Biotechnolgy in Q3 2022 and held it in 9 quarters.
China Universal Asset Management Company's Nautilus Biotechnolgy position peaked at $70.8K in Q1 2024.
88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2024.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.